COMP <GO>
PEPG vs ORMP // ALTMAN Z-SCORE & DEBT/EQUITY
PepGen Inc. (NASDAQ) VS. Oramed Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: PEPG 1
— ORMP 2
■ METRIC PARITY
LAST: $2.35 (-0.42%) • MKT CAP: $162.8M
balance-sheet
—
LAST: $4.00 (-2.68%) • MKT CAP: $166.4M
balance-sheet
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PEPG VS. ORMP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PEPG | ORMP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 0.70% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -7.80% | -27.20 | ORMP | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -5.20% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 3.80% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 3/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.6 | 35.7 | +5.90 | PEPG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $162.8M | $166.4M | -$3.6M | ORMP | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PEPG REV | ORMP REV | PEPG GROSS % | ORMP GROSS % | PEPG FCF | ORMP FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $262.1M | $2.0M | — | 0.7% | -$81.9M | -$9.2M |
| FY 2024 | $273.7M | $35.8M | — | — | -$82.9M | -$8.4M |
| FY 2023 | $237.3M | $1.3M | — | — | -$69.0M | -$10.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PEPG // BETA —
ORMP // BETA —